MCS (23-32mmHg) alleviate nausea and vomiting in trimester 1 and 2 (1).
MCS (15-20 mmHg) reduce leg pain and increase the quality of life (3).
MCS (20-30 mmHg) improve pain, edema and leg heaviness (6).
MCS (20-30 mmHg) decrease the reflux time and peak reflux velocity in the great/small saphenous veins (7).
MCS (20-30 mmHg) reduce the great/small saphenous vein diameters (6).
These effects can be observed throughout the whole pregnancy when wearing MCS.
For the prevention of venous thromboembolic events (VTE), MCS are recommended throughout the entire pregnancy up to six weeks after natural birth, or up to six months after a cesarean section (8).
MCS (20-30mmHg) worn during a cesarean section effectively reduce post-spinal maternal hypotension and neonatal acidosis (10).
Medical compression stockings provide multiple benefits throughout pregnancy and beyond:
MCS are recommended throughout the entire pregnancy (1)(3)(6)(7)(8) and childbirth (5)(9)(10) for up to six weeks after natural birth, or six months after a cesarean section (8). Because pregnancy-related venous indications may persist or worsen over time (3), SIGVARIS GROUP recommends the continued wearing of MCS post-pregnancy.